Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists

Recombinant human erythropoietin (rHuEPO) has been used as a performance‐enhancing agent by athletes in a variety of sports. The resulting increase in hematocrit levels leads to increased blood viscosity and can affect blood flow, potentially increasing the athlete's risk of developing health c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Physiol Rep
Autori principali: Birkhoff, Willem A. J., Heuberger, Jules A. A. C., Post, Titiaan E., Gal, Pim, Stuurman, Frederik E., Burggraaf, Jacobus, Cohen, Adam F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308108/
https://ncbi.nlm.nih.gov/pubmed/30592183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13924
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi